|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
45,510,000 |
Market
Cap: |
17.34(B) |
Last
Volume: |
20,609,857 |
Avg
Vol: |
7,325,175 |
52
Week Range: |
$381.02 - $381.02 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile ABIOMED is a provider of medical devices that provide circulatory support and oxygenation. Co.'s existing products include: Impella 2.5®, which is a percutaneous heart pump with a motor and sensors; Impella CP®, which is primarily used by either interventional cardiologists to support patients in the cath lab or by cardiac surgeons in the heart surgery suite; Impella 5.0® and Impella LD®, which are percutaneous heart pumps with motors and sensors for use primarily in the heart surgery suite; Impella 5.5®, which is designed to be a percutaneous heart pump with motors and sensors; and Abiomed Breethe OXY-1 System, which is a portable external respiratory assistance device.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
11,544 |
Total Sell Value |
$0 |
$0 |
$0 |
$4,345,727 |
Total People Sold |
0 |
0 |
0 |
5 |
Total Sell Transactions |
0 |
0 |
0 |
6 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Puhy Dorothy E |
Director |
|
2018-05-07 |
4 |
AS |
$345.10 |
$4,698,566 |
D/D |
(13,500) |
33,168 |
|
- |
|
Puhy Dorothy E |
Director |
|
2018-05-07 |
4 |
OE |
$9.99 |
$134,865 |
D/D |
13,500 |
46,668 |
|
- |
|
Bolt William J |
SVP, QA and Regulatory Affairs |
|
2018-05-07 |
4 |
AS |
$345.21 |
$7,931,660 |
D/D |
(22,790) |
57,624 |
|
- |
|
Bolt William J |
SVP, QA and Regulatory Affairs |
|
2018-05-07 |
4 |
OE |
$21.55 |
$654,467 |
D/D |
15,666 |
80,414 |
|
- |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2018-05-07 |
4 |
AS |
$345.09 |
$6,091,997 |
D/D |
(17,500) |
46,757 |
|
- |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2018-05-07 |
4 |
OE |
$21.55 |
$377,125 |
D/D |
17,500 |
64,257 |
|
- |
|
Trapp Todd A |
Vice President, CFO |
|
2018-04-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,288 |
6,288 |
|
- |
|
Bolt William J |
SVP, QA and Regulatory Affairs |
|
2018-03-31 |
4 |
A |
$290.99 |
$24,734 |
D/D |
85 |
64,748 |
|
- |
|
Greenfield Andrew J |
VP Healthcare Solutions |
|
2018-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
42 |
42,159 |
|
- |
|
Sutter Martin P |
Director |
|
2018-03-31 |
4 |
A |
$290.99 |
$16,877 |
D/D |
58 |
166,377 |
|
- |
|
Minogue Michael R |
President, CEO, Chairman |
|
2018-03-31 |
4 |
A |
$290.99 |
$24,734 |
D/D |
85 |
169,018 |
|
- |
|
Greenfield Andrew J |
VP Healthcare Solutions |
|
2018-02-20 |
4 |
GA |
$0.00 |
$0 |
I/I |
6,970 |
6,970 |
|
- |
|
Greenfield Andrew J |
VP Healthcare Solutions |
|
2018-02-20 |
4 |
AS |
$268.32 |
$5,407,282 |
D/D |
(20,000) |
49,087 |
|
- |
|
Greenfield Andrew J |
VP Healthcare Solutions |
|
2018-02-20 |
4 |
OE |
$14.39 |
$411,200 |
D/D |
20,000 |
69,087 |
|
- |
|
Greenfield Andrew J |
VP Healthcare Solutions |
|
2018-02-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,970 |
42,117 |
|
- |
|
Sutter Martin P |
Director |
|
2017-12-31 |
4 |
A |
$187.41 |
$16,867 |
D/D |
90 |
166,319 |
|
- |
|
Minogue Michael R |
President, CEO, Chairman |
|
2017-11-30 |
4 |
GA |
$0.00 |
$0 |
I/I |
15,000 |
38,000 |
|
- |
|
Minogue Michael R |
President, CEO, Chairman |
|
2017-11-30 |
4 |
GD |
$0.00 |
$0 |
I/I |
15,000 |
119,779 |
|
- |
|
Minogue Michael R |
President, CEO, Chairman |
|
2017-11-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,399 |
134,779 |
|
- |
|
Minogue Michael R |
President, CEO, Chairman |
|
2017-11-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,399 |
158,619 |
|
- |
|
Puhy Dorothy E |
Director |
|
2017-11-09 |
4 |
GA |
$0.00 |
$0 |
I/I |
11,335 |
11,335 |
|
- |
|
Puhy Dorothy E |
Director |
|
2017-11-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,335 |
21,833 |
|
- |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2017-10-30 |
4 |
AS |
$177.89 |
$1,786,426 |
D/D |
(10,000) |
46,757 |
|
- |
|
Puhy Dorothy E |
Director |
|
2017-10-30 |
4 |
AS |
$178.77 |
$1,139,638 |
D/D |
(6,364) |
33,168 |
|
- |
|
Puhy Dorothy E |
Director |
|
2017-10-30 |
4 |
OE |
$7.67 |
$103,545 |
D/D |
13,500 |
39,532 |
|
- |
|
740 Records found
|
|
Page 15 of 30 |
|
|